Royalty Pharma PLC (RPRX) — SC 13D/A Filings
All SC 13D/A filings from Royalty Pharma PLC. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Royalty Pharma SC 13D/A Amendment Filed
— Jul 29, 2024 Risk: medium
On July 29, 2024, Royalty Pharma plc filed an amendment (No. 4) to its Schedule 13D. The filing indicates changes in beneficial ownership by a group including A
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX